Home > Category > Inhibitory Antibodies > Antibodies > Bispecific monoclonal antibody > Anti-Human EGFRxMET Bispecific Antibody(Amivantamab; JNJ-61186372)

Anti-Human EGFRxMET Bispecific Antibody(Amivantamab; JNJ-61186372)

ChemLeader 95+%
Catalog No:CLA1578 CAS No.:2171511-58-1 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity

There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Anti-Human EGFRxMET Bispecific Antibody(Amivantamab; JNJ-61186372)
CAS2171511-58-1
Storage condition-20°C for 3 years | In solvent: -80°C for 1 year
Product details

Amivantamab (JNJ-61186372) is a fully human EGFR-MET bispecific antibody that combats resistance in NSCLC through multifaceted mechanisms: ligand blockade, receptor degradation, and immune cell activation, including ADCC and trogocytosis. This innovative approach targets both primary and acquired resistance, offering a new therapeutic avenue for patients with EGFR and MET aberrations.

Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays